192 related articles for article (PubMed ID: 1324280)
1. Role of complement in endotoxin/platelet-activating factor-induced lung injury.
Rabinovici R; Yeh CG; Hillegass LM; Griswold DE; DiMartino MJ; Vernick J; Fong KL; Feuerstein G
J Immunol; 1992 Sep; 149(5):1744-50. PubMed ID: 1324280
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.
Rabinovici R; Bugelski PJ; Esser KM; Hillegass LM; Griswold DE; Vernick J; Feuerstein G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1550-7. PubMed ID: 8263817
[TBL] [Abstract][Full Text] [Related]
3. Aspiration-induced lung injury: role of complement.
Rabinovici R; Neville LF; Abdullah F; Phillip DR; Vernick J; Fong KL; Hillegas L; Feuerstein G
Crit Care Med; 1995 Aug; 23(8):1405-11. PubMed ID: 7634812
[TBL] [Abstract][Full Text] [Related]
4. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.
Rabinovici R; Bugelski PJ; Esser KM; Hillegass LM; Vernick J; Feuerstein G
J Appl Physiol (1985); 1993 Apr; 74(4):1791-802. PubMed ID: 8514698
[TBL] [Abstract][Full Text] [Related]
5. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
Mulligan MS; Yeh CG; Rudolph AR; Ward PA
J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine abrogates acute lung injury induced by endotoxin.
Kao SJ; Wang D; Lin HI; Chen HI
Clin Exp Pharmacol Physiol; 2006; 33(1-2):33-40. PubMed ID: 16445696
[TBL] [Abstract][Full Text] [Related]
8. Reduction of total hemolytic complement activity with Naja haje cobra venom factor does not prevent endotoxin-induced lung injury in sheep.
Flick MR; Horn JK; Hoeffel JM; Goldstein IM
Am Rev Respir Dis; 1986 Jan; 133(1):62-7. PubMed ID: 3510582
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
Miotla JM; Jeffery PK; Hellewell PG
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):197-204. PubMed ID: 9476906
[TBL] [Abstract][Full Text] [Related]
10. The role of complement in cigarette smoke-induced chemotactic activity of lung fluids.
Kew RR; Ghebrehiwet B; Janoff A
Am Rev Respir Dis; 1986 Mar; 133(3):478-81. PubMed ID: 3954255
[TBL] [Abstract][Full Text] [Related]
11. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
Till GO; Morganroth ML; Kunkel R; Ward PA
Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
[TBL] [Abstract][Full Text] [Related]
12. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
14. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine.
Schmid RA; Zollinger A; Singer T; Hillinger S; Leon-Wyss JR; Schöb OM; Høgåsen K; Zünd G; Patterson GA; Weder W
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):90-7. PubMed ID: 9671902
[TBL] [Abstract][Full Text] [Related]
15. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat.
Hill J; Lindsay TF; Ortiz F; Yeh CG; Hechtman HB; Moore FD
J Immunol; 1992 Sep; 149(5):1723-8. PubMed ID: 1387151
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl cysteine attenuates acute lung injury in the rat.
Davreux CJ; Soric I; Nathens AB; Watson RW; McGilvray ID; Suntres ZE; Shek PN; Rotstein OD
Shock; 1997 Dec; 8(6):432-8. PubMed ID: 9421857
[TBL] [Abstract][Full Text] [Related]
17. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.
Salzer WL; McCall CE
J Clin Invest; 1990 Apr; 85(4):1135-43. PubMed ID: 2318970
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model.
Darien BJ; Fareed J; Centgraf KS; Hart AP; MacWilliams PS; Clayton MK; Wolf H; Kruse-Elliott KT
Shock; 1998 Apr; 9(4):274-81. PubMed ID: 9565256
[TBL] [Abstract][Full Text] [Related]
20. Embelia ribes ameliorates lipopolysaccharide-induced acute respiratory distress syndrome.
Shirole RL; Shirole NL; Saraf MN
J Ethnopharmacol; 2015 Jun; 168():356-63. PubMed ID: 25818695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
